1. Home
  2. HOTH vs REBN Comparison

HOTH vs REBN Comparison

Compare HOTH & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOTH
  • REBN
  • Stock Information
  • Founded
  • HOTH 2017
  • REBN 2015
  • Country
  • HOTH United States
  • REBN United States
  • Employees
  • HOTH N/A
  • REBN N/A
  • Industry
  • HOTH Biotechnology: Pharmaceutical Preparations
  • REBN Restaurants
  • Sector
  • HOTH Health Care
  • REBN Consumer Discretionary
  • Exchange
  • HOTH Nasdaq
  • REBN Nasdaq
  • Market Cap
  • HOTH 15.6M
  • REBN 15.3M
  • IPO Year
  • HOTH 2019
  • REBN 2022
  • Fundamental
  • Price
  • HOTH $1.51
  • REBN $2.41
  • Analyst Decision
  • HOTH Strong Buy
  • REBN
  • Analyst Count
  • HOTH 3
  • REBN 0
  • Target Price
  • HOTH $4.00
  • REBN N/A
  • AVG Volume (30 Days)
  • HOTH 1.3M
  • REBN 86.6K
  • Earning Date
  • HOTH 11-11-2025
  • REBN 11-18-2025
  • Dividend Yield
  • HOTH N/A
  • REBN N/A
  • EPS Growth
  • HOTH N/A
  • REBN N/A
  • EPS
  • HOTH N/A
  • REBN N/A
  • Revenue
  • HOTH N/A
  • REBN $6,565,623.00
  • Revenue This Year
  • HOTH N/A
  • REBN $335.98
  • Revenue Next Year
  • HOTH N/A
  • REBN N/A
  • P/E Ratio
  • HOTH N/A
  • REBN N/A
  • Revenue Growth
  • HOTH N/A
  • REBN 14.03
  • 52 Week Low
  • HOTH $0.65
  • REBN $1.03
  • 52 Week High
  • HOTH $3.80
  • REBN $8.30
  • Technical
  • Relative Strength Index (RSI)
  • HOTH 44.02
  • REBN 40.52
  • Support Level
  • HOTH $1.49
  • REBN $2.46
  • Resistance Level
  • HOTH $1.62
  • REBN $2.62
  • Average True Range (ATR)
  • HOTH 0.14
  • REBN 0.11
  • MACD
  • HOTH -0.05
  • REBN 0.01
  • Stochastic Oscillator
  • HOTH 6.11
  • REBN 9.09

About HOTH Hoth Therapeutics Inc.

Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).

About REBN Reborn Coffee Inc.

Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.

Share on Social Networks: